These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22348921)

  • 1. The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-up.
    Ruetsch C; Tkacz J; McPherson TL; Cacciola J
    Addict Behav; 2012 May; 37(5):686-9. PubMed ID: 22348921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
    Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
    J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
    Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE
    J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE; Chawarski M; O'Connor PG; Schottenfeld RS; Fiellin DA
    Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.
    Parran TV; Adelman CA; Merkin B; Pagano ME; Defranco R; Ionescu RA; Mace AG
    Drug Alcohol Depend; 2010 Jan; 106(1):56-60. PubMed ID: 19717249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample description.
    Ruetsch C; Cacciola J; Tkacz J
    J Subst Abuse Treat; 2010 Dec; 39(4):307-17. PubMed ID: 20728299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.
    Tkacz J; Severt J; Cacciola J; Ruetsch C
    Am J Addict; 2012; 21(1):55-62. PubMed ID: 22211347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
    Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
    Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
    Reece AS
    J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.
    Kissin W; McLeod C; Sonnefeld J; Stanton A
    J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
    Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F
    Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs.
    Nordbø A; Skurtveit S; Borchgrevink PC; Kaasa S; Fredheim OM
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):88-94. PubMed ID: 22092357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment.
    Tkacz J; Severt J; Kassed C; Ruetsch C
    J Addict Dis; 2012; 31(2):100-11. PubMed ID: 22540432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.
    Warden D; Subramaniam GA; Carmody T; Woody GE; Minhajuddin A; Poole SA; Potter J; Fishman M; Bogenschutz M; Patkar A; Trivedi MH
    Addict Behav; 2012 Sep; 37(9):1046-53. PubMed ID: 22626890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J; Trinh L; Butler B; Randall D; Rubin G
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.